| Metric | FY 2011↕ | FY 2010↕ | FY 2009↕ |
|---|---|---|---|
| Revenue | — | — | — |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| R&D Expense | — | — | — |
| SG&A Expense | — | — | — |
| Operating Income | $2.1B | $1.9B | $1.9B |
| Net Income | $1.1B | $1.0B | $1.2B |
| EPS (Basic) | — | — | — |
| EPS (Diluted) | — | — | — |
| Metric | FY 2011↕ | FY 2010↕ | FY 2009↕ |
|---|---|---|---|
| Total Assets | $40.3B | $35.9B | $32.5B |
| Current Assets | $2.6B | $2.5B | $2.3B |
| Cash & Equivalents | $0.1B | $0.3B | $0.5B |
| Total Liabilities | $30.4B | $26.7B | $23.8B |
| Current Liabilities | $3.8B | $3.3B | $3.0B |
| Stockholders' Equity | — | — | — |
| Metric | FY 2011↕ | FY 2010↕ | FY 2009↕ |
|---|---|---|---|
| Operating Cash Flow | $3.3B | $3.4B | $4.1B |
| Investing Cash Flow | $-4.3B | $-4.1B | $-3.2B |
| Capital Expenditures | $4.1B | $3.8B | $3.0B |
| Financing Cash Flow | $0.8B | $0.5B | $-2.0B |